1,140
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

RAB26 contributes to the progression of non-small cell lung cancer after being transcriptionally activated by SMAD3

, , , &
Pages 8064-8075 | Received 16 Nov 2021, Accepted 05 Mar 2022, Published online: 16 Mar 2022

References

  • Islami F, Ward EM, Sung H, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics. J Natl Cancer Inst. 2021;113(12):1648–1669.
  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
  • Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–1640.
  • Sankar K, Gadgeel SM, Qin A. Molecular therapeutic targets in non-small cell lung cancer. Expert Rev Anticancer Ther. 2020;20(8):647–661.
  • Ao X, Zou L, Wu Y. Regulation of autophagy by the Rab GTPase network. Cell Death Differ. 2014;21(3):348–358.
  • Tzeng HT, Wang YC. Rab-mediated vesicle trafficking in cancer. J Biomed Sci. 2016;23(1):70.
  • Thomas JD, Zhang YJ, Wei YH, et al. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell. 2014;26(5):754–769.
  • Yang XZ, Li XX, Zhang YJ, et al. Rab1 in cell signaling, cancer and other diseases. Oncogene. 2016;35(44):5699–5704.
  • Bi J, Liu H, Cai Z, et al. Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis. Aging (Albany NY). 2018;10(8):1964–1976.
  • Kren N, Michaud D, Bagchi S, et al. Rab27a plays a dual role in metastatic propensity of pancreatic cancer. Sci Rep. 2020;10(1):7390.
  • Hou Q, Wu YH, Grabsch H, et al. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res. 2008;68(12):4623–4630.
  • Liu Q, Wang D, Xu Z, et al. Targeted delivery of Rab26 siRNA with precisely tailored DNA prism for lung cancer therapy. Chembiochem Eur J Chem Biol. 2019;20(9):1139–1144.
  • Liu N, Wu Z, Chen A, et al. SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26. Cell Death Dis. 2019;10(9):667.
  • Itoh Y, Saitoh M, Miyazawa K. Smad3-STAT3 crosstalk in pathophysiological contexts. Acta Biochim Biophys Sin (Shanghai). 2018;50(1):82–90.
  • Qian Z, Zhang Q, Hu Y, et al. Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer. Respir Res. 2018;19(1):262.
  • Tong X, Wang S, Lei Z, et al. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer. Oncogene. 2020;39(14):2890–2904.
  • Han P, Wang XH, Han YF, et al. MicroRNA-140&s inhibition on the cell migration and invasion of non-small cell lung cancer by down-regulating Smad3 expression. Eur Rev Med Pharmacol Sci. 2019;23(21):9471–9479.
  • Vu T, Yang S, Datta PK. MiR-216b/Smad3/BCL-2 axis is involved in smoking-mediated drug resistance in non-small cell lung cancer. Cancers (Basel). 2020;12(7):1879.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. (San Diego, Calif).
  • Nashida T, Imai A, Shimomura H. Relation of Rab26 to the amylase release from rat parotid acinar cells. Arch Oral Biol. 2006;51(2):89–95.
  • Li C, Fan Y, Lan TH, et al. Rab26 modulates the cell surface transport of α2-adrenergic receptors from the Golgi. J Biol Chem. 2012;287(51):42784–42794.
  • Jin RU, Mills JC. RAB26 coordinates lysosome traffic and mitochondrial localization. J Cell Sci. 2014;127(Pt 5):1018–1032.
  • Tian X, Jin RU, Bredemeyer AJ, et al. RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate exocrine granule maturation. Mol Cell Biol. 2010;30(5):1269–1284.
  • Binotti B, Pavlos NJ, Riedel D, et al. The GTPase Rab26 links synaptic vesicles to the autophagy pathway. eLife. 2015;4:e05597.
  • Jin G, Miao R, Hu Z, et al. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. Int J Cancer. 2009;124(9):2172–2178.
  • Tang PC, Chung JY, Xue VW, et al. Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition. Adv Sci. 2022;9(1):e2101235. (Weinheim, Baden-Wurttemberg, Germany).
  • Pan J, Liu Z, Yang Z, et al. Circ_0001686 promotes prostate cancer progression by up-regulating SMAD3/TGFBR2 via miR-411-5p. World J Mens Health. 2022;40(1):149–161.
  • Huang CS, Tsai CH, Yu CP, et al. Long noncoding RNA LINC02470 sponges MicroRNA-143-3p and enhances SMAD3-mediated epithelial-to-mesenchymal transition to promote the aggressive properties of bladder cancer. Cancers (Basel). 2022;14(4):968.
  • Xue J, Lin X, Chiu WT, et al. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis. J Clin Invest. 2014;124(2):564–579.
  • Shi Y, Wang X, Xu Z, et al. PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells. J Biol Chem. 2020;295(40):13798–13811.